|
JP2001526228A
(ja)
|
1997-12-22 |
2001-12-18 |
ユーロ−セルティーク，エス．エイ． |
オピオイド作動薬／拮抗薬の併用
|
|
ES2226933T3
(es)
|
1999-11-01 |
2005-04-01 |
John Rhodes |
Composicion para tratar el estreñimiento y el sindrome del intestino irritable.
|
|
HU229705B1
(en)
|
2000-02-08 |
2014-05-28 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
SI1416842T1
(sl)
|
2001-07-18 |
2009-06-30 |
Euro Celtique Sa |
Farmacevtske kombinacije oksikodona in naloksona
|
|
ATE431738T1
(de)
|
2001-08-06 |
2009-06-15 |
Euro Celtique Sa |
Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
|
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
EP1492505B1
(en)
|
2002-04-05 |
2015-06-03 |
Euro-Celtique S.A. |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
US7501433B2
(en)
*
|
2002-05-17 |
2009-03-10 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
US7815934B2
(en)
|
2002-09-20 |
2010-10-19 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
|
EP1911763B1
(en)
|
2003-01-28 |
2010-08-11 |
Ironwood Pharmaceuticals, Inc. |
Compositions for the treatment of gastrointestinal disorders
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CA2811272C
(en)
|
2003-04-08 |
2016-12-20 |
Progenics Pharmaceuticals, Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
|
MXPA05010819A
(es)
*
|
2003-04-08 |
2006-03-30 |
Progenics Pharm Inc |
Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US8017622B2
(en)
|
2003-05-16 |
2011-09-13 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
CA2560613C
(en)
*
|
2004-03-22 |
2015-11-24 |
Solvay Pharmaceuticals Gmbh |
Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
ES2714198T3
(es)
|
2005-03-07 |
2019-05-27 |
Univ Chicago |
Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
|
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
HUE031042T2
(en)
|
2005-07-29 |
2017-06-28 |
Abbott Laboratories Gmbh |
Methods for producing pancreatin powder with low viral content
|
|
US11266607B2
(en)
*
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
|
US9198871B2
(en)
*
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
|
DK1931316T4
(en)
*
|
2005-08-15 |
2017-05-15 |
Abbott Laboratories Gmbh |
Controlled-release pharmaceutical compositions for use in acid-labile drugs
|
|
US20070185145A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Royds Robert B |
Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
|
|
CA2649881A1
(en)
*
|
2006-04-19 |
2007-11-01 |
Jill P. Smith |
Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
|
|
US10072256B2
(en)
*
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
SI2719378T1
(sl)
|
2006-06-19 |
2016-11-30 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
TW200817048A
(en)
*
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
|
WO2008033124A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Procter & Gamble Company |
Methods of treatment for ulcerative colitis
|
|
US20100048519A1
(en)
*
|
2006-09-13 |
2010-02-25 |
Chyon-Hwa Yeh |
Methods of treatment for ulcerative colitis using aminosalicylate
|
|
JP2010522756A
(ja)
|
2007-03-29 |
2010-07-08 |
プロジェニックス ファーマシューティカルズ，インコーポレーテッド |
結晶形およびその使用
|
|
EP2565195B1
(en)
|
2007-03-29 |
2015-05-06 |
Wyeth LLC |
Peripheral opioid receptor and antagonists and uses thereof
|
|
PL2137191T3
(pl)
|
2007-03-29 |
2016-12-30 |
|
Antagoniści obwodowego receptora opioidowego i ich zastosowania
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
|
JP2011500686A
(ja)
*
|
2007-10-18 |
2011-01-06 |
アイコ バイオテクノロジー |
オピオイドと中性アンタゴニストを用いる組合せ鎮痛剤
|
|
US20090130063A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Solvay Pharmaceuticals Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
AU2008349873B2
(en)
|
2008-02-06 |
2014-02-13 |
Progenics Pharmaceuticals, Inc. |
Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
|
|
CA2719134C
(en)
|
2008-03-21 |
2015-06-30 |
The University Of Chicago |
Treatment with opioid antagonists and mtor inhibitors
|
|
JP2011519930A
(ja)
*
|
2008-05-07 |
2011-07-14 |
ネクター セラピューティクス |
末梢性オピオイドアンタゴニストの経口投与
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
CA2676881C
(en)
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
|
WO2018129556A1
(en)
|
2017-01-09 |
2018-07-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
MX381407B
(es)
|
2008-12-31 |
2025-03-12 |
Ardelyx Inc |
Compuestos y métodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrógeno (nhe) en el tratamiento de trastornos asociados con retención de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
MY152279A
(en)
|
2009-03-10 |
2014-09-15 |
Euro Celtique Sa |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
EP2421515A2
(de)
*
|
2009-04-22 |
2012-02-29 |
Lars Holger Hermann |
Partikelförmige pharmazeutische zusammensetzung mit einem opioid und einem opioid- antagonisten
|
|
CA2774021A1
(en)
*
|
2009-09-18 |
2011-03-24 |
Adolor Corporation |
Use of opioid receptor antagonist for gastrointestinal tract disorders
|
|
EP2568965A1
(en)
|
2010-05-10 |
2013-03-20 |
Euro-Celtique S.A. |
Combination of active loaded granules with additional actives
|
|
PH12012502083A1
(en)
|
2010-05-10 |
2017-07-26 |
Euro Celtique Sa |
Manufacturing of active-free granules and tablets comprising the same
|
|
MX366293B
(es)
|
2012-08-21 |
2019-07-04 |
Ardelyx Inc |
Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
US10376481B2
(en)
|
2012-08-21 |
2019-08-13 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
MX2015002210A
(es)
*
|
2012-08-29 |
2015-05-08 |
Salix Pharmaceuticals Inc |
Composiciones laxantes y metodos para tratar estreñimiento y enfermedades y condiciones gastrointestinales relacionadas.
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
HRP20191000T1
(hr)
|
2013-04-12 |
2019-09-20 |
Ardelyx, Inc. |
Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata
|
|
US10071089B2
(en)
|
2013-07-23 |
2018-09-11 |
Euro-Celtique S.A. |
Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
|
WO2015071380A1
(en)
|
2013-11-13 |
2015-05-21 |
Euro-Celtique S.A. |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
|
|
EP3229785A2
(de)
*
|
2014-12-08 |
2017-10-18 |
Develco Pharma Schweiz AG |
Naloxon-monopräparat und mehrschichttablette
|
|
US20160256451A1
(en)
*
|
2015-03-06 |
2016-09-08 |
Develco Pharma Schweiz Ag |
Dosage of naloxone
|
|
WO2016193456A2
(en)
*
|
2015-06-03 |
2016-12-08 |
Develco Pharma Schweiz Ag |
Opioid receptor antagonist for use in treating patients with severe constipation
|
|
US9943513B1
(en)
|
2015-10-07 |
2018-04-17 |
Banner Life Sciences Llc |
Opioid abuse deterrent dosage forms
|
|
US10335405B1
(en)
|
2016-05-04 |
2019-07-02 |
Patheon Softgels, Inc. |
Non-burst releasing pharmaceutical composition
|
|
MX395405B
(es)
|
2017-01-09 |
2025-03-25 |
Ardelyx Inc |
Compuestos útiles para tratar trastornos del tracto gastrointestinal.
|
|
MX2019008171A
(es)
|
2017-01-09 |
2020-02-05 |
Ardelyx Inc |
Inhibidores del antiporte mediado por nhe.
|
|
US10335375B2
(en)
|
2017-05-30 |
2019-07-02 |
Patheon Softgels, Inc. |
Anti-overingestion abuse deterrent compositions
|
|
WO2023102491A1
(en)
*
|
2021-12-01 |
2023-06-08 |
Invea Therapeutics, Inc. |
Methods for treating gastrointestinal inflammatory disease
|